REQUEST A DEMO
Total
USD $0.00
Search more companies

Clinlogix Latam S.A.S. "En Liquidacion" (Colombia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Clinlogix Latam S.A.S. "En Liquidacion" Profile Updated: November 17, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Clinlogix Latam S.A.S. "En Liquidacion" is an enterprise based in Colombia. Its main office is in Medellin. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences industry. The enterprise was incorporated on April 03, 2013. There are currently 13 (2023) people employed by Clinlogix Latam S.A.S. "En Liquidacion". There was a net sales revenue drop of 46.67% reported in Clinlogix Latam S.A.S. "En Liquidacion"’s latest financial highlights for 2023. During that time, Clinlogix Latam S.A.S. "En Liquidacion"’s total assets decreased by 49.67%. The net profit margin of Clinlogix Latam S.A.S. "En Liquidacion" decreased by 1.69% in 2023.

Headquarters
Carrera 29 C 10 C 125 Ed Select Business Of 701
Medellin; Antioquia;

Contact Details: Purchase the Clinlogix Latam S.A.S. "En Liquidacion" report to view the information.

Website: http://clinlogix.com

Basic Information
Total Employees:
Purchase the Clinlogix Latam S.A.S. "En Liquidacion" report to view the information.
Outstanding Shares:
Purchase the Clinlogix Latam S.A.S. "En Liquidacion" report to view the information.
Incorporation Date:
April 03, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Clinlogix Latam S.A.S. "En Liquidacion" report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-46.67%
Total operating revenue
-46.86%
Operating profit (EBIT)
95.94%
EBITDA
N/A
Net Profit (Loss) for the Period
28.98%
Total assets
-49.67%
Total equity
-22.84%
Operating Profit Margin (ROS)
4.71%
Net Profit Margin
-1.69%
Return on Equity (ROE)
2.56%
Quick Ratio
1.92%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?